NASDAQ:AVAH Aveanna Healthcare (AVAH) Stock Price, News & Analysis $5.48 +0.06 (+1.11%) (As of 05:11 PM ET) Add Compare Share Share Today's Range$5.31▼$5.6250-Day Range$2.49▼$5.7652-Week Range$0.85▼$5.87Volume289,607 shsAverage Volume159,647 shsMarket Capitalization$1.06 billionP/E RatioN/ADividend YieldN/APrice Target$4.27 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get Aveanna Healthcare alerts: Email Address Aveanna Healthcare MarketRank™ Stock AnalysisAnalyst RatingReduce1.75 Rating ScoreUpside/Downside22.1% Downside$4.27 Price TargetShort InterestHealthy1.34% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.10) to ($0.03) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.0.55 out of 5 starsMedical Sector843rd out of 899 stocksHome Health Care Services Industry8th out of 8 stocks 0.9 Analyst's Opinion Consensus RatingAveanna Healthcare has received a consensus rating of Reduce. The company's average rating score is 1.75, and is based on 1 buy rating, 1 hold rating, and 2 sell ratings.Amount of Analyst CoverageAveanna Healthcare has only been the subject of 3 research reports in the past 90 days.Read more about Aveanna Healthcare's stock forecast and price target. Previous Next 5.0 Short Interest Percentage of Shares Shorted1.34% of the float of Aveanna Healthcare has been sold short.Short Interest Ratio / Days to CoverAveanna Healthcare has a short interest ratio ("days to cover") of 2.9, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Aveanna Healthcare has recently decreased by 18.58%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldAveanna Healthcare does not currently pay a dividend.Dividend GrowthAveanna Healthcare does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for AVAH. Previous Next 2.2 News and Social Media Coverage News SentimentAveanna Healthcare has a news sentiment score of 1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.51 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Aveanna Healthcare this week, compared to 2 articles on an average week.Search InterestOnly 2 people have searched for AVAH on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.MarketBeat FollowsOnly 1 people have added Aveanna Healthcare to their MarketBeat watchlist in the last 30 days. This is a decrease of -67% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Aveanna Healthcare insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 7.80% of the stock of Aveanna Healthcare is held by insiders.Percentage Held by Institutions87.96% of the stock of Aveanna Healthcare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Aveanna Healthcare's insider trading history. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Aveanna Healthcare are expected to grow in the coming year, from ($0.10) to ($0.03) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Aveanna Healthcare is -9.13, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Aveanna Healthcare is -9.13, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Read more about Aveanna Healthcare's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Chaikin AnalyticsSell NVDA Now?Just weeks before last month’s selloff, Citadel – the most successful hedge fund in history – quietly sold 500,000 shares. DE Shaw, which once owned over $1 billion of Nvidia stock , slashed its position by half . The stock has since plunged nearly 10%. What’s happening to what was once Wall Street’s favorite company?What does it mean for your money? About Aveanna Healthcare Stock (NASDAQ:AVAH)Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers PDN services, which include in-home skilled nursing services to medically fragile children and adults; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and employer of record support and personal care services, as well as in-clinic and home-based therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products, including formulas, supplies, and pumps to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.Read More AVAH Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart AVAH Stock News HeadlinesAugust 12, 2024 | finance.yahoo.comAveanna Healthcare Holdings Second Quarter 2024 Earnings: Beats ExpectationsAugust 11, 2024 | finance.yahoo.comEarnings Beat: Aveanna Healthcare Holdings Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their ModelsSeptember 9, 2024 | Chaikin Analytics (Ad)Sell NVDA Now?Just weeks before last month’s selloff, Citadel – the most successful hedge fund in history – quietly sold 500,000 shares. DE Shaw, which once owned over $1 billion of Nvidia stock , slashed its position by half . The stock has since plunged nearly 10%. What’s happening to what was once Wall Street’s favorite company?August 9, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: AMN Healthcare Services (AMN), Verona Pharma (VRNA) and Aveanna Healthcare Holdings (AVAH)August 9, 2024 | msn.comAveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Q2 2024 Earnings Call TranscriptAugust 9, 2024 | seekingalpha.comAveanna Healthcare Holdings Inc. (AVAH) Q2 2024 Earnings Call TranscriptAugust 9, 2024 | msn.comAveanna Healthcare Holdings Non-GAAP EPS of $0.01, revenue of $505MAugust 8, 2024 | markets.businessinsider.comHere's what to expect from Aveanna Healthcare's earningsSeptember 9, 2024 | Chaikin Analytics (Ad)Sell NVDA Now?Just weeks before last month’s selloff, Citadel – the most successful hedge fund in history – quietly sold 500,000 shares. DE Shaw, which once owned over $1 billion of Nvidia stock , slashed its position by half . The stock has since plunged nearly 10%. What’s happening to what was once Wall Street’s favorite company?August 8, 2024 | globenewswire.comAveanna Healthcare Holdings Announces Second Quarter 2024 Financial Results and Revised 2024 OutlookJuly 28, 2024 | finance.yahoo.comAveanna Healthcare Holdings Inc. (AVAH)July 23, 2024 | lse.co.ukAveanna Healthcare Holdings Share Price (AVAH.US)July 18, 2024 | globenewswire.comAveanna Announces Second Quarter 2024 Earnings Release Date and Conference CallMay 20, 2024 | globenewswire.comAveanna to Participate at the UBS Healthcare Services Cape Cod Summit and Jefferies Global Healthcare ConferenceMay 13, 2024 | finance.yahoo.comAveanna Healthcare Holdings Inc. (NASDAQ:AVAH) Q1 2024 Earnings Call TranscriptMay 12, 2024 | finance.yahoo.comAnalyst Estimates: Here's What Brokers Think Of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) After Its First-Quarter ReportMay 10, 2024 | finance.yahoo.comAveanna Healthcare Holdings Inc (AVAH) Q1 2024 Earnings: Revenue Rises, Losses NarrowMay 10, 2024 | finance.yahoo.comAveanna Healthcare Holdings First Quarter 2024 Earnings: Beats ExpectationsSee More Headlines Receive AVAH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Aveanna Healthcare and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/08/2024Today9/09/2024Next Earnings (Estimated)11/14/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Home health care services Sub-IndustryHealthcare Current SymbolNASDAQ:AVAH CUSIPN/A CIK1832332 Webwww.aveanna.com Phone770-441-1580FaxN/AEmployees33,500Year FoundedN/APrice Target and Rating Average Stock Price Target$4.27 High Stock Price Target$5.00 Low Stock Price Target$2.80 Potential Upside/Downside-21.3%Consensus RatingReduce Rating Score (0-4)1.75 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)($0.60) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-134,520,000.00 Net Margins-6.42% Pretax Margin-6.55% Return on EquityN/A Return on Assets-1.47% Debt Debt-to-Equity RatioN/A Current Ratio0.94 Quick Ratio0.94 Sales & Book Value Annual Sales$1.95 billion Price / Sales0.53 Cash Flow$0.55 per share Price / Cash Flow9.80 Book Value($0.62) per share Price / Book-8.74Miscellaneous Outstanding Shares192,379,000Free Float177,373,000Market Cap$1.04 billion OptionableOptionable Beta2.13 7 Energy Stocks to Buy and Hold ForeverDo you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.Get This Free Report Key ExecutivesMr. Rodney D. Windley (Age 76)Executive Chairman Comp: $120.5kMr. Jeffrey S. Shaner (Age 51)CEO & Director Comp: $1.1MMr. Ed Reisz (Age 65)Chief Administrative Officer Comp: $649.39kMr. Matthew Buckhalter (Age 35)CFO & Principal Financial Officer Ms. Deborah Stewart (Age 40)Senior VP & Principal Accounting Officer Mr. Patrick A. Cunningham (Age 68)Chief Compliance Officer Mr. Jerry PerchikChief Legal Officer & SecretaryMs. Korey HinzPresident of Medical SolutionsMs. Kristy RohwedderPresident of Private Duty NursingMr. Shane BrinkerhoffPresident of Home Health & HospiceMore ExecutivesKey CompetitorsApriaNYSE:APRSOC TelemedNASDAQ:TLMDSurgery PartnersNASDAQ:SGRYHims & Hers HealthNYSE:HIMSGuardant HealthNASDAQ:GHView All CompetitorsInstitutional OwnershipMackenzie Financial CorpBought 12,075 shares on 8/15/2024Ownership: 0.024%Renaissance Technologies LLCBought 96,600 shares on 8/9/2024Ownership: 0.082%Acadian Asset Management LLCBought 51,890 shares on 8/6/2024Ownership: 0.042%Bank of New York Mellon CorpBought 9,243 shares on 7/26/2024Ownership: 0.078%View All Institutional Transactions AVAH Stock Analysis - Frequently Asked Questions How have AVAH shares performed this year? Aveanna Healthcare's stock was trading at $2.68 at the beginning of 2024. Since then, AVAH shares have increased by 104.5% and is now trading at $5.48. View the best growth stocks for 2024 here. How were Aveanna Healthcare's earnings last quarter? Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) issued its quarterly earnings data on Thursday, August, 8th. The company reported ($0.01) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.04) by $0.03. The firm had revenue of $504.96 million for the quarter, compared to analysts' expectations of $494.02 million. When did Aveanna Healthcare IPO? Aveanna Healthcare (AVAH) raised $478 million in an initial public offering (IPO) on Thursday, April 29th 2021. The company issued 38,200,000 shares at a price of $12.00-$13.00 per share. Barclays, J.P. Morgan, BMO Capital Markets and Credit Suisse acted as the underwriters for the IPO and BofA Securities, Deutsche Bank Securities, Jefferies, RBC Capital Markets, Truist Securities, Raymond James, Stephens Inc., Drexel Hamilton and Siebert Williams Shank were co-managers. Who are Aveanna Healthcare's major shareholders? Aveanna Healthcare's top institutional shareholders include Renaissance Technologies LLC (0.08%), Bank of New York Mellon Corp (0.08%), Acadian Asset Management LLC (0.04%) and Mackenzie Financial Corp (0.02%). Insiders that own company stock include Tony Strange, Jeff Shaner, David Afshar, Victor F Ganzi, Patrick A Cunningham and Steven E Rodgers. View institutional ownership trends. How do I buy shares of Aveanna Healthcare? Shares of AVAH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:AVAH) was last updated on 9/9/2024 by MarketBeat.com Staff From Our PartnersWall Street’s Best-Kept SecretWe're about to let you in on Wall Street's best-kept secret… For decades we've watched big institutions and...Unstoppable Prosperity | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredSell NVDA Now?Just weeks before last month’s selloff, Citadel – the most successful hedge fund in history – quietly sold 500...Chaikin Analytics | Sponsored‘Wheels Are Falling Off’ the U.S. Stock Market"Wheels Are Falling Off" The U.S. Stock Market Today, analyst Dan Ferris is back issuing a new warning. He ...Stansberry Research | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aveanna Healthcare Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aveanna Healthcare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
